Bayer Pharma’s President Speaks of Results in the West and Prospects in Japan
This article was originally published in PharmAsia News
At a press conference held in Osaka July 4, Bayer Pharma President Andreas Fibich revealed that oral Xa inhibitor Xarelto, which was introduced in Japan in April, held 14.2% of the German market share in June.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.